Increase the proportion of adults with diabetes using insulin who monitor their blood sugar daily — D‑07 Data Methodology and Measurement

About the National Data


Baseline: 89.0 percent of adults aged 18 years and over with diagnosed diabetes using insulin performed self-monitoring of blood glucose at least once daily in 2017

Target: 94.4 percent

Number of adults aged 18 years and over with diabetes and taking insulin who report that they check their blood for glucose or sugar by themselves or by a family member or friend (excludes health professional) at least once a day.
Number of adults aged 18 years and over who report that they have ever been told they have diabetes and taking insulin.
Target-setting method
Percentage point improvement
Target-setting method details
Percentage point improvement from the baseline using Cohen's h effect size of 0.20.
Target-setting method justification
Trend data were not available for this objective. A percentage point improvement was calculated using Cohen's h effect size of 0.2. This method was used because it was a statistically significant improvement from the baseline.


Methodology notes

Persons are considered to have diabetes if they have ever been told by a doctor or health professional that they have diabetes or sugar diabetes. Women who report that the only time they have been diagnosed with diabetes was during pregnancy (gestational diabetes) are excluded. Persons who reported borderline or prediabetes are also excluded. The BRFSS is conducted independently by each state and therefore methodologies may vary. Pooled national estimates may not take into account these differences and so may differ from estimates obtained using data sources that use methodologies designed to produce national estimates.


Comparable HP2020 objective
Modified, which includes core objectives that are continuing from Healthy People 2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from Healthy People 2020 objective D-13 in that objective D-13 tracked adults with diagnosed diabetes who performed self-blood glucose-monitoring at least once daily, while this objective tracks adults with diabetes using insulin who perform self-monitoring of blood glucose at least once daily.
Trend issues

Data for this objective are collected using the core component and an optional module of the BRFSS, which is made available to States for administration annually. The number of States that select the diabetes module varies every year. The measure is the mean of data for the reporting States. In 2017, 39 States including DC used the optional module excluding: AR, CT, HI, ID, IL, ME, MA, MS, OR, SD, TN, and WV. In 2018, 19 States (including DC) used the optional module including, AL, AZ, DE, DC, GA, IA, ME, MA, MS, NJ, ND, OH, OK, SC, SD, TN, TX, VA, and WI. In 2019, 31 States (including DC)used the optional module excluding AZ, AR, CO, FL, GA, HI, ID, MA, MS, NV, NJ, NY, OR, RI, SC, SD, TN, VT, WA, and WV.

1. Effect size h=0.2 was chosen to correspond with 20% improvement from a baseline of 50%.